Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
d-CON is a leading American brand of rodenticide products, specializing in the development and commercialization of solutions for controlling mice and rats. Originally established as an independent company in 1950, it is currently a subsidiary of the global consumer health and hygiene company Reckitt. The brand's product portfolio includes a variety of baits, traps, and bait stations that utilize chemical agents such as anticoagulants and cholecalciferol to manage rodent populations. d-CON plays a significant role in public health by mitigating the risks associated with rodent-borne diseases in residential and commercial environments. The brand is widely recognized for its retail presence and its transition toward more environmentally conscious and pet-safe baiting technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on d-CON.